Status:
COMPLETED
Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
Lead Sponsor:
Bayer
Collaborating Sponsors:
Janssen Research & Development, LLC
Conditions:
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Eligibility:
All Genders
18+ years
Brief Summary
This is a local, prospective, multicenter, non-interventional, observational study. Primary objective is to describe how in "real life" thromboprophylaxis is carried out after the discharge from a hos...
Eligibility Criteria
Inclusion
- Male and female patients ≥ 18 years old
- Elective hip or knee replacement
- Planned VTE prevention with Xarelto
- Written informed consent
- The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study.
Exclusion
- Contraindications for the use of Xarelto in accordance with the effective instruction
- Any reasons of medical and non-medical character, which in the opinion of the physician can hamper participation of the patient in NIS, including a potentially low compliance, impossibility of making the final visit due to distant place of residence of the patient.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
2293 Patients enrolled
Trial Details
Trial ID
NCT01444586
Start Date
October 1 2011
End Date
July 1 2014
Last Update
January 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Russia